Tpr-Met was generated following a chromosomal rearrangement induced by the treatment of a human osteogenic sarcoma cell line with the carcinogen N-methyl-N'-nitronitrosoguanidine.
Publikácia vzišla z pera biskupa talianskej diecézy v Trieste Mons. Giampaola Crepaldiho, predsedu Medzinárodného observatória kardinála Van Thuâna pre sociálnu...
Authors: Chiara Crepaldi and Francesca Pepé, Istituto per la Ricerca Sociale Contributions to this report by: Iva Kuchyňková and Martina Veverková, Caritas Czech Republic Coordination: Peter Verhaeghe and Shannon Pfohman, Caritas Europa